{
    "medicine_id": "9d2b95f55c0a34b40dd4bee415b47968673c4727",
    "platform_id": "DB11584",
    "metadata": {
        "name": "Alertonic 3 23 g L Injection solution",
        "composition": "3 23 g L Pipradrol",
        "clinical_particulars": {
            "therapeutic_indications": "Used to manage fatigue L2522 and depression L2515 A32724 L2518 L2523 Used as an adjunct therapy in the management of obesity L2522",
            "contraindications": {
                "disease": "Toxicity Data Oral LD50 rat 180 mg kg Oral LD50 mouse 120 mg kg Oral LD50 rabbit 180 mg kg MSDS The toxicity of this drug is dependent on the dose ingested and is owed to its central nervous stimulant activity T178 T179 Overdoses of pipradrol hydrochloride cause nausea anxiety insomnia and abdominal pain however these symptoms often disappear when the drug is withdrawn In severe cases convulsions may occur L2515 T179 This drug is contraindicated in anxiety psychosis states and schizophrenia as it can worsen these symptoms Hallucinations have been reported after taking this drug T178 Over the last decade there has been greater use of novel psychoactive substances legal highs across Europe and the United States including increasing frequency of reports of diphenylprolinol D2PM and desoxypipradrol 2 DPMP use L2519 There are increasing reports that D2PM desoxy analogue of pipradrol and 2 DPMP a pyrrolidine analogue of pipradrol are used in Europe as drugs of abuse 2 DPMP has sympathomimetic properties similar to cocaine and in addition prolonged and clinically significant neuropsychiatric symptoms have been reported L2519 The binding and activity of D2PM at the dopamine re uptake transporter is also similar to cocaine though it appears that D2PM has less potent biological activity L2519",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Pipradrol Meratran is a psychoactive agent and a central nervous system stimulant that has proven useful in the field of psychiatry L2522 Pipradrol was initially used as an adjunct in the dietary management of obesity as well as for the management of dementia symptoms Numerous reports have been made on the properties of pipradrol demonstrating its favorable effects in the treatment of depression and fatigue in addition to a variety of other conditions including narcolepsy spasmodic torticollis schizophrenia and in geriatric practice L2522",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}